These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23954501)

  • 1. Potency of progestogens used in hormonal therapy: toward understanding differential actions.
    Hapgood JP; Africander D; Louw R; Ray RM; Rohwer JM
    J Steroid Biochem Mol Biol; 2014 Jul; 142():39-47. PubMed ID: 23954501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology of estrogens and progestogens: influence of different routes of administration.
    Kuhl H
    Climacteric; 2005 Aug; 8 Suppl 1():3-63. PubMed ID: 16112947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic and non-genomic actions of progestogens in the breast.
    Mueck AO; Ruan X; Seeger H; Fehm T; Neubauer H
    J Steroid Biochem Mol Biol; 2014 Jul; 142():62-7. PubMed ID: 23994274
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects.
    Stanczyk FZ; Hapgood JP; Winer S; Mishell DR
    Endocr Rev; 2013 Apr; 34(2):171-208. PubMed ID: 23238854
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative cardiovascular effects of different progestins in menopause.
    Rosano GM; Fini M
    Int J Fertil Womens Med; 2001; 46(5):248-56. PubMed ID: 11720197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A review of the cardiovascular and breast actions of drospirenone in preclinical studies.
    Simoncini T; Genazzani AR
    Climacteric; 2010 Feb; 13(1):22-33. PubMed ID: 19938948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contents of HRT and mechanisms of action.
    Leake R
    J Epidemiol Biostat; 1999; 4(3):129-33; discussion 133-9. PubMed ID: 10695955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms of steroid receptor-mediated actions by synthetic progestins used in HRT and contraception.
    Africander D; Verhoog N; Hapgood JP
    Steroids; 2011 Jun; 76(7):636-52. PubMed ID: 21414337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progestogens in postmenopausal hormone therapy and the risk of breast cancer.
    Lambrinoudaki I
    Maturitas; 2014 Apr; 77(4):311-7. PubMed ID: 24485796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The rationale for a wider range of progestogens.
    Skouby SO
    Climacteric; 2000 Dec; 3 Suppl 2():14-20. PubMed ID: 11379382
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships between chemical structure and biological properties of progestogens.
    Rozenbaum H
    Am J Obstet Gynecol; 1982 Mar; 142(6 Pt 2):719-24. PubMed ID: 7065053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
    van Leeuwen FE
    Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progestogens in hormonal replacement therapy: new molecules, risks, and benefits.
    Sitruk-Ware R
    Menopause; 2002; 9(1):6-15. PubMed ID: 11791081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hormonal contraception and substitution therapy: the importance of progestogen for cardiovascular diseases].
    Kuhl H
    Geburtshilfe Frauenheilkd; 1992 Nov; 52(11):653-62. PubMed ID: 1452000
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progestogens exhibit progestogen-, promoter- and isoform-specific effects via the progesterone receptor.
    Enfield K; Avenant C; Hapgood JP
    Steroids; 2022 Nov; 187():109094. PubMed ID: 35905833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contraception for the perimenopausal patient.
    Upton GV
    Obstet Gynecol Clin North Am; 1987 Mar; 14(1):207-27. PubMed ID: 3306520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternate delivery systems for contraceptive progestogens.
    Ginsburg KA; Moghissi KS
    Fertil Steril; 1988 May; 49(5 Suppl 2):16S-30S. PubMed ID: 3282932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Vascular effects of gestagens--biochemistry versus epidemiology].
    Kuhl H
    Zentralbl Gynakol; 1999; 121(2):67-78. PubMed ID: 10096172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of progestins used in hormonal contraception and progesterone via the progesterone receptor.
    Enfield K; Cartwright M; Toit RL; Avenant C; Africander D; Hapgood JP
    Biochem Biophys Res Commun; 2020 Dec; 533(4):879-885. PubMed ID: 33008590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolism of progestogens used for contraception and menopausal hormone therapy.
    Stanczyk FZ; McGough A; Chagam L; Sitruk-Ware R
    Steroids; 2024 Jul; 207():109427. PubMed ID: 38663566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.